New York A 5953: Relates to the availability of buprenorphine in opioid treatment programs

Status: REFERRED TO ALCOHOLISM AND DRUG ABUSE (as of 2020-01-08)

State: New York · Session: 2019-2020 · Bill: A 5953

Sponsors: ROSENTHAL L

View New York A 5953 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.